Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic brea...
by Miles, David W. (Author)
, Chan, Arlene (Author)
, Dirix, Luc Y. (Author)
, Cortés, Javier (Author)
, Pivot, Xavier (Author)
, Tomczak, Piotr (Author)
, Delozier, Thierry (Author)
, Sohn, Joo Hyuk (Author)
, Provencher, Louise (Author)
, Puglisi, Fabio (Author)
, Harbeck, Nadia (Author)
, Steger, Guenther G. (Author)
, Schneeweiss, Andreas (Author)
, Wardley, Andrew M. (Author)
, Chlistalla, Andreas (Author)
, Romieu, Gilles (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource